Genzyme Corp. broke ground on a 177,000-sf research facility in Framingham, Mass., on October 5, 2005. The $124-million project consists of a six-story research building and a separate utilities facility that will provide services to it and three other Genzyme buildings in Framingham. The research facility will feature a six-story atrium with offices and labs designed to promote collaboration and interaction.
The University of North Carolina is partnering with Dole Food Company, North Carolina State University, developer David Murdock, and other institutions to create the 350-acre North Carolina Research Campus in Kannapolis. Upon completion, the campus will comprise over one million square feet of office and laboratory space as well as commercial, retail, and residential facilities. The first 330,000-sf building will include:
The Novartis Institutes for Biomedical Research is planning to construct a new five-story facility adjacent to its existing building in Cambridge, Mass. Sited on land owned by the Massachusetts Institute of Technology, the 60,000-sf facility is expected to begin construction in fall 2005 and reach completion in a year. The project will house Novartis' administrative staff as well as including ground-floor retail space. The architect for the project is Elkus Manfredi of Boston.
Construction is sixty percent complete on Marshall University 's Robert G. Byrd Biotechnology Center in Huntington, W.V. The $42-million, six-story structure will accommodate two auditoriums, three teaching labs, several conference rooms, and approximately 45 laboratories. Slated for completion in fall 2006, the facility will be open for classes in January 2007. The center is the Marshall University's largest capital improvement project to date.
The Hudson-Alpha Institute for Biotechnology will construct a $130-million research institute and campus in Huntsville, Ala., by 2007. Sited on 120 acres in the Cummings Research Park, the project will be the second largest biotechnology institute on the second largest biotech campus in the nation upon completion. The north wing will house eight science teams and the south wing will house eight small biotech companies that can expand to sites in the biotech park to accommodate growth.
Human Genome Sciences (HGS) is nearing completion of its $250-million manufacturing facility in Rockville, Md. Sited on ten acres on the Belward Research Campus of Johns Hopkins University near HGS' existing headquarters, the 290,000-sf facility will enable HGS to produce several different biotech drugs on a commercial scale including human proteins, antibodies, and fusion proteins created by the joining of two genes. Construction is expected to reach completion by year-end 2005 with validation of the facility to follow in 2006.
Swiss pharmaceutical maker Novartis AG has renovated the historic 1927 New England Candy Co. factory in Cambridge to create a 500,000-sf biomedical research facility. The renovated building now houses labs, offices, breakout rooms, a 180-seat auditorium, two conference rooms, and a six-story atrium. Designed to foster interaction and collaboration, the labs and offices are co-located, with breakout rooms and kitchens on the perimeter of each floor. The building features state-of-the-art power, water, air handling, communications, and security systems.
The University of Florida is developing the 23,500-gsf Center of Excellence for Regenerative Heath Biotechnology in Alachua County, Fla. Sited 13 miles from the University's Gainesville campus in the Sid Martin Biotechnology Development Incubator in the Progress Corporate Park, the facility will house up to 11,080 sf of cleanrooms and support space.
Worcester Polytechnic Institute (WPI) broke ground on June 27, 2005 on a life sciences and bioengineering center in Worcester, Mass. Sited on a former industrial brownfield, the 14-story center is the first facility in a planned 11-acre life sciences development called Gateway Parklife sciences park. WPI's 124,600-sf center is slated for completion in early 2007 and will accommodate laboratories, support facilities, and a renovated industrial building housing meeting rooms and offices.
Nabi BioPharmaceuticals dedicated its new 12,000-sf vaccine manufacturing facility in Boca Raton, Fla., in June, 2005. Sited at the company's existing headquarters, the $20-million facility will produce StaphVax, a vaccine for the prevention of hospital-born staph infections.
Biotechnology firm Genitope is relocating its headquarters and manufacturing operations from Redwood City to 220,0000 sf in Fremont, Calif. Genitope has signed two fifteen and a half year leases for two facilities in the Ardenwood Technology Park at $2.35 per square foot or $517,000 per month. The facilities, which will cost $60 million to build out, will be occupied by Genitope upon completion of construction in 2006.
Bayer Healthcare has completed a 100,000-sf office and laboratory facility in Norwood, Mass. Designed by Margulies & Associatesof Boston, the new space consists of 80,000 sf of administrative offices and support areas as well as 20,000 sf of laboratories. Supporting the company's Diagnostics Division, the facility includes visitor and training labs, a test methods lab, an analytical lab, a systems engineering lab, storage for chemicals, and controlled-temperature storage coolers.
The $100 million California Institute for Quantitative Biomedical Research is nearing completion at the Mission Bay campus in South San Francisco. The 153,000-sf facility is the first of four buildings that will make up the institute known as QB3 and is connected to U.C. San Francisco's Genentech Hall on all five stories. The Mission Bay facility will house a magnetic resonance imaging machine, a high through-put screening facility, a 250,000-compound chemical library for drug development, and 8,000 CPUs.
Translational Genomics (TGen) will officially dedicate its new $46 million headquarters on March 22, 2005. Located in Phoenix, Ariz., the TGen headquarters is sited in a 173,000-sf building, the first in a new downtown campus called the Phoenix Bioscience Center at Cooper Square. Other tenants in the building include the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), occupying the entire 23,000-sf second floor, and the International Genomics Consortium (IGC).
Clark University will dedicate the new Cathy '83 and Marc '81 Center for Bioscience on April 28, 2005. Designed by Tsoi/Kobus and Associates of Cambridge, the 50,000-sf facility houses two classrooms; twelve research labs; seven teaching labs; two conference rooms; fourteen faculty offices; a sequencing facility; a dark room; and three lounges.
